遗传多态化的影响个性化饮食和炼计划的脂肪性肝病
Norio Akuta1, Yusuke Kawamura1, Shunichiro Fujiyama1
1Department of Hepatology, Toranomon Hospital and Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
概括
个性化的饮食和运动计划有效治疗脂肪性肝病 (SLD). 遗传变异可能会影响治疗结果,这表明需要个性化方法.
科学领域:
- 肝病学和胃肠道学
- 代谢障碍 代谢障碍 代谢障碍
- 遗传学 遗传学 是一个
背景情况:
- 脂肪性肝病 (SLD) 是一个日益严重的健康问题,对治疗的遗传影响尚不清楚.
- 个性化的生活方式干预对于管理SLD至关重要.
- 了解遗传多态化可以优化SLD治疗策略.
研究的目的:
- 评估针对SLD个性化的饮食和运动计划的有效性.
- 研究遗传多态性对SLD患者治疗结果的影响.
主要方法:
- 对203名日本SLD患者进行了回顾性队列研究.
- 6个月的标准化个性化饮食 (25-30 kcal/kg理想体重) 和运动 (4-5 MET).
- 评估肝功能,代谢标志物,身体和图像发现,以及心血管疾病风险评分.
主要成果:
- 在肝功能测试,糖脂代谢,体重,BMI,肝硬度和心血管疾病风险评分中观察到显著改善.
- 在PNPLA3,TM6SF2和HSD17B13中的遗传多态性显示,整体治疗疗效没有显著差异.
- TM6SF2和HSD17B13基因型影响了甘油三降低率.
结论:
- 个性化的饮食和运动计划对于改善SLD标志物是有效的.
- 遗传多形态可能部分影响治疗反应,特别是甘油三水平.
- 需要进一步的研究来制定基因型引导的个性化SLD治疗计划.
相关概念视频
Cell Specific Gene Expression
13.6K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
13.6K
Liver Physiology
620
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
620
Hepatic Drug Excretion: Influencing Factors
152
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
152
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
61
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
61
Factors Affecting Drug Biotransformation: Biological
177
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
177
Overview of Lipid Metabolism
1.7K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.7K


